Ansun BioPharma

OverviewSuggest Edit

Ansun BioPharma is a biopharmaceutical company focused on the development of host-directed anti-viral therapies for respiratory viruses. The company aims to invent, test, and deliver recombinant therapeutic proteins to treat diseases affecting vulnerable patients.

TypePrivate
Founded2003
HQSan Diego, CA, US
Websiteansunbiopharma.com
Employee Ratings4.1
Overall CultureB

Latest Updates

Employees (est.) (Jul 2021)27(-3%)

Key People/Management at Ansun BioPharma

Nancy Chang

Nancy Chang

CEO and Chairperson of the Board
George Wang

George Wang

CTO
Yining Zhao

Yining Zhao

President and Chief Operating Officer
Haiyan Jiang

Haiyan Jiang

Chief Scientific Officer
Shuanglian Li

Shuanglian Li

Senior Vice President
Show more

Ansun BioPharma Office Locations

Ansun BioPharma has an office in San Diego
San Diego, CA, US (HQ)
3030 Callan Rd
Show all (1)

Ansun BioPharma Financials and Metrics

Summary Metrics

Founding Date

2003

Ansun BioPharma total Funding

$183.9 m

Ansun BioPharma latest funding size

$80 m

Time since last funding

2 years ago

Ansun BioPharma investors

Ansun BioPharma's latest funding round in October 2019 was reported to be $80 m. In total, Ansun BioPharma has raised $183.9 m
Show all financial metrics

Ansun BioPharma Online and Social Media Presence

Embed Graph

Ansun BioPharma Company Culture

  • Overall Culture

    B

    83/100

  • CEO Rating

    A+

    97/100

  • Compensation

    B

    79/100

  • Diversity

    B

    81/100

Learn more on Comparably

Ansun BioPharma News and Updates

Ansun Biopharma to Present at H.C. Wainwright & Co. 22nd Annual Global Investment Conference

SAN DIEGO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Ansun Biopharma, Inc., a clinical stage biopharmaceutical company, today announced the company will present at the H.C. Wainwright & Co. 22nd Annual Global Investment Conference, taking place September 14-16. During the conference, Nancy Chang, Ph.…

Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment

SAN DIEGO, April 2, 2020 /PRNewswire/ -- Ansun Biopharma, Inc., a clinical stage biopharmaceutical company, today announced preliminary data from an investigator-initiated trial of DAS181, a recombinant sialidase with broad antiviral properties, for the treatment of severe COVID-19...

Ansun BioPharma Frequently Asked Questions

  • When was Ansun BioPharma founded?

    Ansun BioPharma was founded in 2003.

  • Who are Ansun BioPharma key executives?

    Ansun BioPharma's key executives are Nancy Chang, George Wang and Yining Zhao.

  • How many employees does Ansun BioPharma have?

    Ansun BioPharma has 27 employees.

  • Who are Ansun BioPharma competitors?

    Competitors of Ansun BioPharma include Abiogen Pharma, PlasmaGen Biosciences and Alexion Pharmaceuticals.

  • Where is Ansun BioPharma headquarters?

    Ansun BioPharma headquarters is located at 3030 Callan Rd, San Diego.

  • Where are Ansun BioPharma offices?

    Ansun BioPharma has an office in San Diego.

  • How many offices does Ansun BioPharma have?

    Ansun BioPharma has 1 office.